Denali Therapeutics, Inc. (DNLI)
17.31
+0.24
(+1.41%)
USD |
NASDAQ |
Jan 09, 13:10
Denali Therapeutics Research and Development Expense (Annual): 396.44M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Enovis Corp. | 91.30M |
| Masimo Corp. | 222.80M |
| Novavax, Inc. | 388.77M |
| Protalix Biotherapeutics, Inc. | 12.97M |
| Twist Bioscience Corp. | 80.28M |